Previous meta-analyses have demonstrated that blood BDNF levels were significantly decreased in patients with Alzheimer’s disease, whereas blood NGF and VEGF levels did not show significant differences between patients with Alzheimer’s disease and control subjects82. This evidence concerns the gene NGF and early-onset autosomal dominant Alzheimer disease.